Latest news
Adverse Event Management for Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 12:42:09 GMTMulti-Channel Engagement and Pharmacist-Prescriber Collaboration in Tardive Dyskinesia Care - Pharmacy TimesPharmacy Times · Tue, 04 Aug 2026 20:36:41 GMTHow Subcutaneous Isatuximab Could Compete With Daratumumab in Multiple Myeloma - Pharmacy TimesPharmacy Times · Tue, 28 Jul 2026 20:03:31 GMT